Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021
   PCE(x) 16.66--

What is the latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA is 16.66 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202316.66
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of PIRAMAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 16.66
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,784.0 Cr 0.4% 5.4% 110.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,290.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹113,357.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹111,134.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹104,235.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,001.5 Cr -1% -2.4% 28.4% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.4%

5.4%

110.9%

SENSEX

1.7%

1.5%

18.7%


You may also like the below Video Courses